inDegree, who is developing an alumni tracking service for schools and students, beats 5 others to win $100k at Alabama Launchpad.
UAB ophthalmologists are studying the role of a lipoprotein in macular degeneration.
Research on how enzymes regulate the progress of a blood cancer wins recognition.
Four of 6 teams competing for $100,000 grand prize from UAB
UAB study finds multi-tasking teens using media almost all day, each day; sleep is disrupted and parents are kept in the dark
Early study finds brighter fluorescent lights prevent myopia.
UAB research reveals sleep-deprived adolescents experience more hits and near misses while crossing the street in virtual lab.
Tim Townes, Ph.D., was awarded the HudsonAlpha Prize for his work on sickle-cell disease and related blood disorders.
Biotech company developed at UAB wins economic development funding.
UAB leads national update of RA treatment guidelines.
Researchers were surprised by a second effect of an established drug.
Six outstanding undergraduates will do research under the mentorship of top UAB researchers.
UAB cyber-crime expert will be featured on NBC Wednesday.
UAB’s Center for Palliative Care is in an online battle with other hospitals for cancer grants from Lance Armstrong’s LIVESTRONG organization.
Turner-Henson has been recognized by the EPA for her work in children's health initiatives.
Research suggests that a class of drugs for rheumatoid arthritis seeking approval this year could be effective against other autoimmune diseases.
UAB anthropology researchers will present papers at a conference hosted at UAB.
UAB launches statewide initiative to investigate, prosecute cyber-criminals accustomed to flying below the radar.
UAB researcher will study the possible connection between cholesterol and kidney function in lupus patients.
The event will be a day of collaboration among faculty, clinicians, postdocs and students with an interest in basic and clinical immunology.
UAB study reveals loss of sales and use tax from online purchases costs Alabama revenue, thousands of jobs each year.
Children with juvenile idiopathic arthritis are at an increased risk for cancer, but a drug suspected of contributing to that risk may not be the culprit.